Sign Up Today and Learn More About Inscripta Stock
Invest in or calculate the value of your shares in Inscripta or other pre-IPO companies through EquityZen's platform.
Inscripta Stock
Inscripta is a gene editing technology company.
Inscripta is a gene-editing technology company.
About Inscripta Stock
Founded
2015
Headquarters
Boulder, CO, US
Notable Investor
NanoDimension
Total Funding
84.5M
Industries
Inscripta is a gene-editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, forward cell-engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene-editing tools (instruments, reagents, and software) that will significantly increase the speed and efficiency of multiplexed, precision gene editing. By removing the barriers to forward cell engineering and gene-editing research, Inscripta will usher in a new era of advances to revolutionize how we feed, fuel, and heal humanity. Inscripta is led by several genomic technology veterans including CEO Kevin Ness, who co-founded QuantaLife and 10x Genomics, and John Stuelpnagel, the chairman of the company's board, who was co-founder and first CEO of Illumina and chairman of 10x Genomics. Inscripta is headquartered in Boulder, Colo.; has offices in Pleasanton, Calif.; and is backed by Venrock, MLS Capital, NanoDimension, Foresite, Paladin Capital Group, and MĂŠrieux DĂŠveloppement.
Inscripta Press Mentions
Stay in the know about the latest news on Inscripta
Inscripta Is Reimagining What The Synthetic Biology Company Of The Future Will Be
forbes ⢠Jan 25, 2023
In bid to advance manufacturing capabilities, Inscripta buys out two biotechs
endpts ⢠Jan 20, 2023
Inscripta Acquires Infinome Biosciences, Sestina Bio
genomeweb ⢠Jan 19, 2023
Inscripta Acquires Former Illumina Team via Solana Biosciences to Commercialize Gene Editing Tools
agfundernews ⢠Jan 12, 2023
Inscripta to close Boulder HQ, triggering âmass layoffâ
bizwest ⢠Dec 20, 2022
Investors in Inscripta
Discover investors in Inscripta stock and explore their portfolio companies
Inscripta Management
Leadership team at Inscripta
General Counsel
Dianna DeVore
VP Finance
Eric Warnecke
Join now and verify your accreditation status to gain access to:
- Inscripta current valuation
- Inscripta stock price
- Available deals in Inscripta and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Inscripta stock?
Accredited investors can buy pre-IPO stock in companies like Inscripta through EquityZen funds. These investments are made available by existing Inscripta shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event â house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Inscripta stock?
Shareholders can sell their Inscripta stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
